Roche to take stake in LumiraDx diagnostics platform

The Swiss drugmaker has announced that it will buy LumiraDx's Point of Care diagnostics platform business for c.$295m. Founded in 2014, LumiraDx has been developing a diagnostic platform that supports a broad menu of tests at the point of care.

Read the full article.